Thema: CH0012005267
Novartis, CH0012005267
Novartis AG CH0012005267 – Pharmatechniker bedient eine industrielle Tablettenpresse in dokumentarischer Schwarzweißfotografie - Foto: THN
Novartis stock gains as Q3 core profit lifts 2026 outlook
Novartis stock follows stronger core earnings after the drugmaker raised its 2026 profit outlook. A major impairment weighed on reported profit.
ad-hoc-news.de, 30.10.26 16:01 Uhr
Novartis, CH0012005267
Novartis stock gets outlook lift as core earnings advance ...
Novartis stock follows a stronger core earnings outlook after the pharmaceutical group reported third-quarter growth. A major impairment clouded reported profit.
ad-hoc-news.de, 30.10.26 09:47 Uhr
Novartis, CH0012005267
Novartis stock reaches EUR 143.81 after outlook upgrade
Novartis stock extends its post-results advance as stronger core earnings support the outlook. Pipeline setbacks keep investor sentiment divided.
ad-hoc-news.de, 29.10.26 17:51 Uhr
Novartis, CH0012005267
Novartis raises 2026 profit outlook. Novartis stock gains ...
Sales rose 4.00 percent to USD 14.52 billion for July-September. Novartis stock costs EUR 139.69 on October 27, 2026, up 1.89 percent versus Xetra close.
ad-hoc-news.de, 27.10.26 16:51 Uhr
Novartis, CH0012005267
Novartis raises 2026 core income guidance for Novartis stock ...
Novartis lifted its 2026 core income view from decline to growth. Novartis stock costs EUR 140.03 on October 27, 2026.
ad-hoc-news.de, 27.10.26 10:16 Uhr
Novartis, CH0012005267
RBC sets a CHF 120.00 target for Novartis stock
Novartis has results due October 27, 2026. Novartis stock costs EUR 137.74 on October 26, 2026, minus 0.75 percent versus Xetra close.
ad-hoc-news.de, 26.10.26 16:48 Uhr
Novartis, CH0012005267
Barclays cuts target for Novartis stock to CHF 125
Barclays cuts its target from CHF 130 to CHF 125. Novartis stock costs EUR 137.99 on October 26, 2026, 0.57 percent below Xetra close.
ad-hoc-news.de, 26.10.26 09:42 Uhr
Novartis, CH0012005267
Novartis stock has results on October 27 ahead of the Xetra ...
The pharmaceutical group is due to report third-quarter results on October 27, 2026. At Lang & Schwarz the stock trades pre-market at EUR 135.59 on October 26, 2026.
ad-hoc-news.de, 26.10.26 08:04 Uhr
Novartis, CH0012005267
Novartis reports trial data as Novartis stock trades at ...
Novartis stock costs EUR 135.50 in weekend trading on October 25, 2026. Novartis reported two Phase III trial updates.
ad-hoc-news.de, 25.10.26 17:18 Uhr
Novartis, CH0012005267
Novartis highlights global ranking as Novartis stock trades ...
